Last updated: April 25, 2026
Who Supplies Empagliflozin and Metformin Hydrochloride for Pharma Manufacturing?
What suppliers produce empagliflozin APIs and branded intermediates?
Empagliflozin is manufactured globally by multiple API and intermediate suppliers under commercial and toll manufacturing models. The most consistently cited large-scale API/HPAPI suppliers for empagliflozin include:
| Supplier |
What they supply |
Typical role in projects |
| Boehringer Ingelheim |
Empagliflozin drug substance (API) for commercial supply chains tied to Jardiance |
Innovator supply |
| Zhejiang Medicine / related API complex suppliers in China |
Empagliflozin API (and related steps) for global customers |
Commercial API supply |
| Sun Pharma (via API manufacturing footprint) |
Empagliflozin API |
Commercial supply |
| Alkem Laboratories (via API manufacturing footprint) |
Empagliflozin-related API supply |
Commercial supply |
| Dr. Reddy’s Laboratories (via API manufacturing footprint) |
Empagliflozin API supply |
Commercial supply |
| Hetero Labs (via API manufacturing footprint) |
Empagliflozin API supply |
Commercial supply |
Notes for sourcing teams
- Empagliflozin supply is typically built from API + key intermediates; many customers qualify multiple API sources to reduce allocation risk.
- Pricing and lead times vary by whether the customer buys API only or uses a supplier that supports direct intermediate-to-API sequencing.
Regulatory anchor (reference product)
- Empagliflozin is the active ingredient of Jardiance (Boehringer Ingelheim) and related fixed-dose products. FDA and EMA submissions for Jardiance reference the API and manufacturing supply chain under Good Manufacturing Practice (GMP) controls. [1], [2]
What suppliers produce metformin hydrochloride APIs?
Metformin hydrochloride is a widely manufactured generic API with high supply density across China, India, and Europe. Commonly listed suppliers include:
| Supplier |
What they supply |
Typical role in projects |
| Merck (EMD Serono / Merck KGaA supply chain) |
Metformin hydrochloride API for global markets |
Large Western supplier |
| Teva API / Teva manufacturing network |
Metformin hydrochloride API |
Commercial supply |
| Sandoz (API and branded generic supply network) |
Metformin hydrochloride API |
Commercial supply |
| Cipla (API manufacturing footprint) |
Metformin hydrochloride API |
Commercial supply |
| Dr. Reddy’s Laboratories |
Metformin hydrochloride API |
Commercial supply |
| Wuxi Xinhua / other major China metformin API producers |
Metformin hydrochloride API |
High-volume commercial supply |
Notes for sourcing teams
- Metformin hydrochloride is commonly supplied as API with broad global documentation packages for abbreviated approval pathways and direct manufacturing use in generics.
- Suppliers often offer multiple grades tied to particle size, residual solvents, and impurity profiles (e.g., aldehydes, N-nitrosamines control in later regulatory cycles).
Regulatory anchor (reference product)
- Metformin hydrochloride is the active ingredient in long-standing reference products such as Glucophage (Bristol Myers Squibb historically) and numerous generics. FDA product labeling and regulatory histories connect metformin’s API supply and impurity controls to ongoing CMC expectations. [3]
Which suppliers are most relevant for due diligence and qualification?
For qualification and vendor onboarding, the most actionable targets are suppliers that support:
- Full GMP documentation: CoA, DMF/EDMF cross-references where applicable, batch manufacturing records, and validation packages.
- Change control and impurity trend control (especially for empagliflozin HPAPI steps and metformin impurity and nitrosamine controls).
- Scalable supply: multi-source production runs across at least two facilities or contracts with toll capability.
What determines which supplier you should prioritize?
Empagliflozin and metformin hydrochloride are both CMC-sensitive, but the supplier choice shifts by drug type:
Empagliflozin
- Higher complexity HPAPI chain and tighter impurity control drive selection toward suppliers with established empagliflozin commercial track records.
- Projects frequently qualify suppliers with proven ability to deliver consistent impurity profiles and robust analytical method packages. [1], [2]
Metformin hydrochloride
- Lower structural complexity makes supply broader, so vendor selection often prioritizes documentation completeness, quality history, and compliance readiness tied to regulatory impurity expectations. [3]
Key Takeaways
- Empagliflozin is supplied by a smaller set of large-scale API/HPAPI manufacturers plus regional toll producers; top-tier qualification typically targets suppliers with established commercial supply history tied to Jardiance-linked CMC expectations. [1], [2]
- Metformin hydrochloride has dense global API supply with many credible producers; supplier selection tends to focus on GMP package strength, impurity control readiness, and supply reliability rather than unique synthetic capability. [3]
- For both drugs, the highest ROI sourcing path is qualifying multiple vendors based on GMP documentation quality, impurity control, and supply scalability rather than relying on a single source.
FAQs
-
Can I source empagliflozin from multiple API vendors for commercial production?
Yes. Commercial programs commonly qualify more than one API supplier to manage allocation and continuity risk, with vendor selection based on impurity profile control and documentation strength. [1], [2]
-
Is metformin hydrochloride easier to source than empagliflozin?
Yes. Metformin hydrochloride has higher global manufacturing density, so sourcing typically faces fewer HPAPI-specific constraints than empagliflozin. [3]
-
Which suppliers are most credible for first-pass qualification?
Suppliers with established commercial production track records and complete GMP/CMC documentation packages aligned to FDA and EMA expectations for the reference products. [1]-[3]
-
What quality criteria matter most for empagliflozin API?
Impurity profile consistency, analytical method suitability, and change control maturity tied to GMP batch performance and regulatory expectations. [1], [2]
-
What quality criteria matter most for metformin hydrochloride API?
Impurity controls, residual solvent/processing controls, and documentation readiness tied to evolving regulatory impurity expectations across approvals and inspections. [3]
References
[1] FDA. Jardiance (empagliflozin) Prescribing Information. U.S. Food and Drug Administration.
[2] EMA. Jardiance (empagliflozin) EPAR and assessment documentation. European Medicines Agency.
[3] FDA. Glucophage (metformin hydrochloride) Prescribing Information and regulatory history. U.S. Food and Drug Administration.
